Transdermal Scopolamine Market to Reach Value of Approximately US$585.3 Mn by the End of 2024
The global Transdermal Scopolamine Market is witnessing a remarkable rise, thanks to rising awareness among consumers regarding it being highly effective in treating motion sickness. The increasing number of travelers across the world is adding substantially to the growth of this market. Transdermal scopolamine also finds application during surgeries as it helps in avoiding hyper salivation and aids in recovery from post-operative and anesthesia-induced nausea and vomiting. As a result of the noticeable rise in the number of surgeries performed...
View full press release